Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06681935 · ClinicalTrials.gov registry record
Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery
A clinical trial of Oral Cancer, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06681935: Recruiting study of Oral Cancer, sponsored by Medical College of Wisconsin.
NCT06681935 is a study of Oral Cancer that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 40 participants, below the 211-participant average among 17 other Oral Cancer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06681935, a study of Oral Cancer, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The study design is an observational cohort study of patients undergoing standard of care oral cavity reconstruction. An observational study is required to prospectively evaluate microbial and antibiotic mechanisms underlying surgical site infection after oral cavity reconstruction.
Primary Outcome
This is the number of subjects with surgical site infections with bacteria that originates from the oral cavity. This will be determined by metagenomic mapping of bacterial strains causing surgical site infection back on to the metagenomic samples from their anatomic source (oral cavity, nasal cavity, pharyngoesophagus, donor site skin).
Conditions Studied
Interventions
- PROCEDURE Oral Cavity Reconstruction
Study Locations (1)
Wisconsin
- Froedtert & the Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-04-29 |
| Est. Completion | 2027-05-01 |
What NCT06681935 shows while recruiting
NCT06681935 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 211-participant average among 17 other Oral Cancer trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Oral Cancer appearing as the primary indexed condition, and to 1 intervention - of which Oral Cavity Reconstruction is the first listed.
NCT06681935 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06681935 about?
NCT06681935 is a clinical study titled "Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery". The study design is an observational cohort study of patients undergoing standard of care oral cavity reconstruction. An observational study is required to prospectively evaluate microbial and antibiotic mechanisms underlying surgical site infection after oral cavity reconstruction.
What is the current status of trial NCT06681935?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-04-29. Estimated completion is 2027-05-01.
What conditions does trial NCT06681935 study?
This clinical trial studies the following conditions: Oral Cancer.
What interventions are being tested in trial NCT06681935?
The interventions under investigation include: Oral Cavity Reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT06681935?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06681935 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oral Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06681935's enrollment target sits among peer trials
40 12th of 17 higher than 4 of 17 other Oral Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oral Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
RECRUITING · NA
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
RECRUITING
-
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
RECRUITING · NA
-
Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
RECRUITING · NA
-
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI